Technology News and Research

RSS

Highlights of AAPM 52nd meeting

The 52nd meeting of the American Association of Physicists in Medicine (AAPM) convenes from July 18 - 22, 2010 in Philadelphia, PA.

14 Jul 2010

Silence Therapeutics extends ongoing research, development collaboration with AstraZeneca

Silence Therapeutics plc is pleased to announce a one-year extension of its ongoing research and development collaboration with AstraZeneca. Under the terms of the agreement, which has progressed well since being signed in July 2007, Silence and AstraZeneca are jointly collaborating in the identification and optimization of five novel siRNA therapeutic molecules addressing respiratory and oncology indications.

14 Jul 2010

Improved delivery methods needed to advance gene therapy strategies for prostate cancer: Review

Improved delivery methods and better testing systems are needed to advance promising gene therapy strategies for treating prostate cancer, according to a series of review articles in Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc.

14 Jul 2010

MTBC welcomes final rule on meaningful use of EHR

MTBC, a unique healthcare IT company, welcomed today's release by the U.S. Department of Health and Human Services of the final rule on what constitutes "meaningful use" of an Electronic Health Record.

14 Jul 2010

Skin cell samples may help discover factors behind Parkinson's disease

Researchers are applying new stem cell technology to use skin samples to grow the brain cells thought to be responsible for the onset of Parkinson's disease

14 Jul 2010

CRT, MRCT to swap medical discoveries to advance translation of scientific research

Cancer Research Technology and Medical Research Council Technology will 'swap' medical discoveries to accelerate the translation of early scientific research into patient benefit.

14 Jul 2010

TheraDoc clinical surveillance system helps clinicians reduce catheter-related infections: Study

Hospira, Inc., a leading provider of clinical information and medication delivery technologies, today announced a study showing how the TheraDoc clinical surveillance system helped clinicians at Memorial Hospital Miramar reduce catheter-related infections, which correlated with an increase in infection-control interventions.

14 Jul 2010

NCCS supports two final rules issued by CMS, ONC for EHR incentive programs

The National Coalition for Cancer Survivorship announced its support of the two final rules issued by the Centers for Medicare and Medicaid Services and the Office of the National Coordinator for Health Information Technology for the electronic health record incentive programs at a briefing hosted by the U.S. Department of Health and Human Services today.

14 Jul 2010

Individual genes and networks that play an important role in inflammation, atherosclerosis identified

HemoShear, LLC, a leading developer of innovative, cell-based, human surrogate models for discovery and assessment of new drug compounds, has produced a profile of all of the genes that influence the biology and function of the human artery system. This research has generated valuable information on the entire spectrum of genes that are found in specific cell-types that make up human arteries.

14 Jul 2010

Kinetico's in-home water filtration options decrease exposure to carcinogens

In its most recent annual report, the President's Cancer Panel lists in-home water filtration as a way to decrease exposure to both known and suspected carcinogens as well as endocrine disruptors. Kinetico's line of in-home treatment options provides multiple resources for water filtration, in line with the PCP's recommended solution to lower in-home exposure to carcinogens.

14 Jul 2010

Brookhaven Science Associates, BioSET receive U.S. patent for tissue regeneration technology

Brookhaven Science Associates, the company that manages the U.S. Department of Energy's Brookhaven National Laboratory, and Biosurface Engineering Technologies, Inc. of Rockville, Maryland, have been issued a U.S. patent for an improved second-generation technology for designing synthetic peptides that are important for tissue regeneration.

14 Jul 2010

Evidence-based guidelines could help prevent dangerous radiation overdoses, says MedSolutions

Utilization management programs that use evidence-based guidelines to ensure appropriate use of diagnostic imaging tests could help prevent dangerous radiation overdoses like the one highlighted in a recent New England Journal of Medicine editorial, said MedSolutions, a leading provider of medical management services.

14 Jul 2010

InfoLogix granted extension of time to regain compliance with NASDAQ listing requirements

InfoLogix, Inc., a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, today announced that it received a letter from NASDAQ on July 8, 2010, stating that a NASDAQ Hearings Panel granted the Company's request for an extension of time, as permitted under NASDAQ's Listing Rules, to regain compliance with the $2.5 million minimum stockholders' equity requirement for continued listing on the NASDAQ Stock Market.

14 Jul 2010

HTDS announces involvement in divestiture of subsidiary Collagenna

Hard to Treat Diseases, Inc. is pleased to share that HTDS is currently involved in discussions regarding a divestiture of subsidiary Collagenna.

14 Jul 2010

ACRO releases statement regarding proposed privacy rule from HHS

The Association of Clinical Research Organization is pleased that the proposed privacy rule from Department of Health and Human Services strikes an appropriate balance between the critical needs of researchers for access to health information and the desire to protect the privacy of individual's health records.

14 Jul 2010

UMMC receives $26M to identify risk factors for Alzheimer's disease

The University of Mississippi Medical Center and four collaborating academic medical centers have received $26 million from the National Institutes of Health to identify risk factors for Alzheimer's disease and related forms of cognitive decline, said Dr. Thomas Mosley, UMMC professor of geriatric medicine and one of the new study's lead investigators.

14 Jul 2010

InQ Biosciences to launch fully integrated Cell Research System

InQ Biosciences, a provider of innovative technologies for cell growth and research, announced its plans to launch the InQ™ Cell Research System during the fourth quarter of 2010. InQ is the first fully integrated system that creates a high fidelity in vivo environment for studying stem cells, plus nerve, brain, and other mammalian cells for disease research.

14 Jul 2010

Valentus Medical Technologies signs partnership agreement with Medical Tactile for SureTouch technology

Medical Tactile, Inc. and Valentus Medical Technologies, Inc. announced today that Valentus Medical Technologies, Inc., based in Victoria, Canada, has signed a partnership agreement with Medical Tactile, Inc., and has taken on the exclusive Sales & Marketing rights for SureTouch™, the non-invasive digital breast imaging technology, worldwide, with the exception of China.

14 Jul 2010

Metamark Genetics closes $22M Series B financing

Metamark Genetics, Inc., a molecular diagnostics company addressing a major challenge in cancer medicine, has completed a $22 million Series B financing. Metamark's Prognosis Determinants platform has illuminated the genetic drivers governing the lethal metastatic progression of major cancers and is now focused on pivotal translational and commercialization efforts to bring these breakthrough discoveries to cancer patients worldwide.

14 Jul 2010

Antigen Express granted patent for AE37 immunotherapeutic vaccine: Generex Biotechnology

Generex Biotechnology Corporation today announced that its wholly-owned subsidiary, Antigen Express, Inc., has been granted a United States patent on AE37, its lead immunotherapeutic vaccine. While Antigen Express has a strong intellectual property foundation on all Ii-Key technology, this is the first "composition of matter" patent to be issued relating to one of their development products.

14 Jul 2010

Technology News and Research

Highlights of AAPM 52nd meeting

Silence Therapeutics extends ongoing research, development collaboration with AstraZeneca

Improved delivery methods needed to advance gene therapy strategies for prostate cancer: Review

MTBC welcomes final rule on meaningful use of EHR

Skin cell samples may help discover factors behind Parkinson's disease

CRT, MRCT to swap medical discoveries to advance translation of scientific research

TheraDoc clinical surveillance system helps clinicians reduce catheter-related infections: Study

NCCS supports two final rules issued by CMS, ONC for EHR incentive programs

Individual genes and networks that play an important role in inflammation, atherosclerosis identified

Kinetico's in-home water filtration options decrease exposure to carcinogens

Brookhaven Science Associates, BioSET receive U.S. patent for tissue regeneration technology

Evidence-based guidelines could help prevent dangerous radiation overdoses, says MedSolutions

InfoLogix granted extension of time to regain compliance with NASDAQ listing requirements

HTDS announces involvement in divestiture of subsidiary Collagenna

ACRO releases statement regarding proposed privacy rule from HHS

UMMC receives $26M to identify risk factors for Alzheimer's disease

InQ Biosciences to launch fully integrated Cell Research System

Valentus Medical Technologies signs partnership agreement with Medical Tactile for SureTouch technology

Metamark Genetics closes $22M Series B financing

Antigen Express granted patent for AE37 immunotherapeutic vaccine: Generex Biotechnology

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News